George Clinical Appoints Tony Proctor as CFO

George Clinical Taps Experienced Financial Leader CFO“>Tony Proctor as New CFO

Singapore-based global clinical research company George Clinical has announced the appointment of Tony Proctor, CPA, as its Chief Financial Officer (CFO). Proctor brings over two decades of experience in financial leadership roles to the position.

Proctor’s Expertise Expected to Drive Financial Growth

“I am honored to join George Clinical and contribute to improving health outcomes through innovative clinical research,” said Proctor. “I look forward to working with the talented team to improve the financial operations and support the company’s global vision.

Prior to joining George Clinical, Proctor served in CFO and leadership positions at several prominent companies within the industry, including Lexitas, Parexel, and Syneos Health. Throughout his impressive career, he has consistently delivered measurable results, driving strategic growth initiatives, and optimizing financial operations on a global scale. Proctor is known for implementing world-class financial disciplines, executing key organizational and systems upgrades, and leading transformative mergers and acquisitions processes.

George Clinical CEO Welcomes Proctor

“We are delighted to welcome Tony to George Clinical during this exciting phase of our growth,” said Mary Gunn, CEO of George Clinical. “His extensive expertise in financial strategy and operational leadership will be instrumental in driving our business forward and delivering exceptional value to our clients around the world.”

Strong Academic Credentials and Certification

Proctor holds an MBA in Finance from Campbell University and earned both a BS in Accounting and a BA in Economics/Finance from North Carolina State University. He is also a Certified Public Accountant (CPA) in North Carolina.

About George Clinical

George Clinical is a world-leading clinical research company headquartered in Singapore. With a commitment to scientific excellence and operational expertise, the company provides comprehensive clinical trial services to customers worldwide. George Clinical offers solutions for all phases of trials and is dedicated to contributing to improved health outcomes worldwide.

For more information about George Clinical, visit www.georgeclinical.com.

What are Tony Proctor’s top⁢ priorities as the⁤ new CFO of George Clinical?

## George Clinical Welcomes New CFO: A Conversation with ⁣Tony ⁤Proctor

**Interviewer:** Welcome,⁤ Tony. Congratulations on your⁢ appointment as⁤ Chief⁤ Financial Officer at George Clinical.⁤

**Tony Proctor:** Thank you. I’m truly excited to be joining⁢ such ​a dynamic and⁤ innovative⁣ company.

**Interviewer:** George Clinical plays a crucial role in advancing⁤ global health through clinical research. Can ‍you tell ⁤us​ about your vision for​ the financial leadership of the company?

**Tony Proctor:** My primary focus ⁤will be ⁢ensuring the ⁣financial stability and growth of George‍ Clinical, ⁤allowing us to continue investing in cutting-edge research and expanding our global footprint. I​ believe my two decades of experience in financial leadership roles will be ‌instrumental in achieving these goals. [[1](https://www.prnewswire.com/news-releases/george-clinical-accueille-tony-proctor-au-poste-de-directeur-financier-302319176.html)]

**Interviewer:** Your statement mentioned “improving health outcomes ⁤through innovative clinical research.” How does the CFO⁣ role contribute to that broader mission?

**Tony Proctor:** ‍Ultimately, financial health underpins‍ all successful endeavors. By managing resources effectively and strategically, I can‌ help ensure that George Clinical has the funding and infrastructure necessary to conduct groundbreaking research that improves lives.

**Interviewer:** What ⁣are you most looking forward to in this new role?

**Tony Proctor:** ‌I’m excited to work ‌with the talented team at George Clinical and contribute to ⁤the company’s‌ continued success.⁣ The opportunity to support the⁣ development of new treatments and therapies that have‍ the potential​ to impact patients worldwide‌ is incredibly motivating.

**Interviewer:** Thank you for ‌your time, Tony. We​ wish you all the best in your new role.

Leave a Replay